This company’s lead product is cultivated pork fat positioned as a drop‑in ingredient to improve flavour, aroma, juiciness, and cooking performance in both hybrid meats and other foods where animal fat functionality matters. The core target market is B2B (food manufacturers and brands) that can incorporate small inclusion rates to create meaningful sensory upgrades without requiring “100% cultivated” products immediately.
Its technology narrative centres on cultivating pig fat cells in bioreactors, combined with modular manufacturing ideas intended to improve cost and scalability. The company frames the product as “cultivated fat” rather than complete muscle cuts, reflecting a strategic focus on the parts of meat that deliver disproportionate sensory value.
Commercial stage: it has publicly stated it submitted its first regulatory dossier to the Singapore Food Agency in late 2025 for cultivated pork fat commercialization in Singapore.
Availability: no open retail availability is indicated; the product remains in pre‑market/regulatory and partner-development steps.
Timeline and regions: Singapore is positioned as an early target market pending approval; broader markets would follow additional submissions, and specific dates are not assured in public materials.
Official website: https://hoxtonfarms.com/